Application of unsaturated tungsten oxide coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment

By coating unsaturated tungsten oxide on the surface of bismuth ferrate, WO3-X-BFO nanomaterials are prepared, and ultrasound and 1064nm laser produce reactive oxygen species, combined with photothermal effect, the problem of large side effects and limited effect of cancer treatment in the prior art is solved. Achieve efficient and safe tumor suppression effect.

CN118987208APending Publication Date: 2024-11-22HARBIN UNIV OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411089344.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing cancer treatment methods such as surgery, radiotherapy and chemotherapy have problems with large side effects and limited therapeutic effects, and the mechanism of recurrence and metastasis of tumor cells is unknown. The application of existing inorganic nanomaterials in tumor treatment has not yet achieved ideal results.

Method used

Unsaturated tungsten oxide was coated on the surface of bismuth ferrate by hydrothermal method to prepare unsaturated tungsten oxide-coated bismuth ferrate nanomaterial (WO3-X-BFO) which produces reactive oxygen species under ultrasound and 1064nm laser. , realize acoustic power, photodynamic and photothermal effects, and are used for non-invasive and efficient tumor treatment.

Benefits of technology

WO3-X-BFO material significantly inhibited tumor growth, with a tumor suppression rate of 78.14%, and has good biocompatibility and safety. No significant pathological changes were seen, which achieved oxidative damage and thermal damage to the tumor, significantly improved. The therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004986076400000011
    Figure HDA0004986076400000011
  • Figure HDA0004986076400000012
    Figure HDA0004986076400000012
  • Figure HDA0004986076400000021
    Figure HDA0004986076400000021
Patent Text Reader

Abstract

The invention provides an unsaturated tungsten oxide coated bismuth ferrite (WO3-X-BFO) piezoelectric semiconductor composite material which is simultaneously used as a piezoelectric electrosensitizer and a photosensitizer to be applied to tumor treatment for the first time, and particularly relates to the technical field of biological medicines. BFO is synthesized through a coprecipitation method, WO3-X-BFO is further synthesized through a hydrothermal method, and all properties of bismuth ferrite are remarkably improved. WO3-X-BFO is subjected to a redox reaction under the action of ultrasound and 1064nm laser to generate active oxygen, and endogenous hydrogen peroxide can be converted into. OH for chemical kinetic therapy. And meanwhile, the material has good photo-thermal conversion performance. According to the invention, the excellent performance of WO3-X-BFO is verified at cell and animal levels. The killing rate for 4T1 cells is 92.05%, the average tumor inhibition rate for 4T1 tumor-bearing mice is 78.14%, and tumor ablation is achieved through oxidative damage and thermal damage under the action of ultrasound and 1064nm laser.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The present invention belongs to the application of nano materials in the field of biomedicine, and specifically relates to unsaturated tungsten oxide coated bismuth ferrite (WO 3-X -BFO) piezoelectric semiconductor composites and their application in tumor therapy. Background technology:

[0002] Cancer is a highly complex and heterogeneous disease with the highest mortality rate worldwide. The metastasis and recurrence of cancer are important factors leading to disability and death, and their exact mechanisms remain to be elucidated. At present, the most common treatment strategies include surgery, radiotherapy and chemotherapy, which can cause primary tumor regression and improve the quality of life of patients in clinical practice. Surgery is an effective means to remove malignant solid tumors, especially in the early stages of tumor development, but surgery cannot completely remove tumor cells and the tumor is very likely to recur after surgery; radiotherapy uses radioactive elements to kill tumor cells, which cannot specifically kill tumor cells during treatment, causing damage to the patient's normal parts and having greater side effects; the therapeutic effect of chemotherapy is limited by the microenvironment in which tumor cells survive and their own drug resistance, making its therapeutic effect limited and having greater side effects. In 2018, there were approximately 18.1 million new cancer cases and 9.6 million deaths from cancer. According to the Global Cancer Observatory (GCO), by 2030, it is estimated that approximately 30 million cancer patients will die from cancer each year. In addition to the high mortality rate of cancer, the economic burden on the families and society of cancer patients is also huge. Therefore, the prevention, diagnosis and treatment of cancer are of great significance.

[0003] Medical nanotechnology uses nanosized materials, usually 1-100 nanometers. These materials are used in the design and manufacture of therapeutic drugs. In recent years, the development of efficient inorganic nanomaterials to kill tumor cells by physical and simple chemical means, such as efficient photothermal conversion efficiency, photocatalysis and sonodynamic generation of reactive oxygen, has become an important research direction for the treatment of tumors. This research direction is still in its infancy, and there are still a lot of scientific problems to be solved in material development and mechanism exploration. Bismuth ferrite (BiFeO3, BFO), as a typical piezoelectric semiconductor material, has a narrow bandgap and is widely used in the field of piezoelectric (photo) catalysis. In order to improve the piezoelectric photocatalytic performance of bismuth ferrite and improve its dispersibility in aqueous solution, the present invention uses a hydrothermal method to coat unsaturated tungsten oxide on the surface of bismuth ferrite to prepare unsaturated tungsten oxide-coated bismuth ferrite nanomaterials (WO 3-X -BFO), which has piezoelectric, photoelectric and photothermal effects at the same time, and is applied in the field of tumor treatment for the first time. Summary of the invention:

[0004] In the present invention, unsaturated tungsten oxide-coated bismuth ferrite nanomaterials are prepared by hydrothermal method, and the synthesized unsaturated tungsten oxide-coated bismuth ferrite nanomaterials have excellent piezoelectric photocatalytic properties. 3-X -BFO forms a built-in electric field that is sufficient to tilt the conduction band to reach the redox potential for generating reactive oxygen species, thereby initiating a cascade reaction to generate reactive oxygen species (ROS). It can also convert endogenous hydrogen peroxide into ·OH for chemodynamic therapy (CDT). In addition, under the action of 1064nm laser, photogenerated electrons are generated to further generate ROS; at the same time, the material exhibits excellent photothermal conversion efficiency. Using WO 3-X -BFO nanomaterials, under the combined action of ultrasound and 1064nm laser, achieve non-invasive and efficient tumor treatment through sonodynamic therapy (SDT), photodynamic therapy (PDT) and photothermal effect (PTT).

[0005] The present invention discloses an application of an unsaturated tungsten oxide-coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment, which mainly involves: preparation and characterization of unsaturated tungsten oxide-coated bismuth ferrite nanomaterials, and application research of the nanomaterial in tumor treatment, which is specifically carried out through the following steps:

[0006] Step 1: Weigh the raw materials bismuth nitrate (pentahydrate, 0.99 mmol) and ferric nitrate (nonahydrate, 1 mmol) respectively, dissolve the bismuth nitrate in dilute nitric acid, ultrasonically dissolve for a period of time, and then add ferric nitrate until it is completely dissolved;

[0007] Step 2: adjusting the pH of the solution to about 9-11, centrifuging the solution to obtain a precipitate, drying it in a vacuum drying oven at 60 degrees for 12 hours, grinding the obtained solid powder and calcining it in a tube furnace at 500 degrees in air for 2 hours, and further washing it by alternating centrifugation with dilute nitric acid and deionized water for 3 times to obtain pure phase bismuth ferrite;

[0008] Step 3: Weigh 0.04-0.17g of tungsten (VI) ethoxide, add 50ml of anhydrous ethanol, stir in a 70°C oil bath until completely dissolved, then add 400mg of pure bismuth ferrite, and disperse evenly by ultrasonication;

[0009] Step 4: Transfer the mixed solution obtained in step 3 to a reactor, and react in an oven at 150-200 degrees for 22 hours. After the reaction is completed, the reaction product is centrifuged and washed several times, and then placed in a vacuum drying oven for 12-24 hours to obtain unsaturated tungsten oxide-coated bismuth ferrite nanoparticles;

[0010] Step 5: 4T1 mouse breast cancer cells were digested with trypsin and resuspended in 1064 culture medium in a 96-well plate for MTT toxicity test and treatment effect test;

[0011] Step 6: 4T1 mouse breast cancer cells were digested with trypsin and centrifuged, then resuspended in PBS solution to a concentration of 0.9-1.2×10 6 The single cell suspension of 100 cells / ml was subcutaneously injected into female Balb / c mice weighing about 18 g to establish a mouse breast cancer model;

[0012] Step 7: Divide the mice into five groups: PBS, PBS+US, WO 3-X -BFO、WO 3-X -BFO+US、WO 3-X -BFO+US+1064 group, tumor volume in each group reached 50mm 3 Treatment started at around 14:00 p.m., and each group was injected intratumorally with PBS or WO 3-X -BFO solution 100ul, treatment for 5min;

[0013] Step 8. The weight and tumor volume of mice were recorded every other day. After the 12-day treatment cycle, the mice were killed, the tumor tissues were removed, and the main organ sections were selected for H&E staining.

[0014] Further limitation: In step 1, bismuth nitrate and ferric nitrate need to be added in sequence until they are completely dissolved.

[0015] Further limitation: The ratio of the dilute nitric acid solution prepared in step 1 should be water: concentrated nitric acid = 32:11.

[0016] Further limitation: In step 3, the concentration of ethanol tungsten (VI) after complete dissolution is 37 mM.

[0017] Further definition: The concentration of 4T1 cell suspension in step 6 is 1×10 6 Pieces / ml.

[0018] Further definition: In step 7, the drug concentration of injection is 20 mg / kg, the ultrasound frequency is 1 MHz, and the power is 2-3 W / cm 2 , the optical power of the 1064nm laser is 1W / cm 2 .

[0019] Advantages and effects of the present invention:

[0020] In the present invention, unsaturated tungsten oxide coated bismuth ferrite nanomaterials are prepared by hydrothermal method and applied to tumor treatment. Unsaturated tungsten oxide is coated on the surface of BFO by hydrothermal method; at the same time, the hydrothermal method also reduces the agglomeration degree of the material, further reduces the surface potential, and makes the material show good dispersibility. WO 3-X -BFO, due to its excellent piezoelectric photocatalytic properties, produces a large amount of reactive oxygen under the action of ultrasound and 1064nm laser. At the same time, due to its excellent photothermal efficiency, it ultimately achieves oxidative damage and thermal damage to the tumor.

[0021] The unsaturated tungsten oxide-coated bismuth ferrite nanomaterial prepared by the present invention can convert endogenous hydrogen peroxide into ·OH for chemodynamic therapy (CDT). Under the action of ultrasound, the built-in electric field generated inside the piezoelectric semiconductor material is conducive to the separation of electron-hole pairs. At the same time, due to the presence of oxygen vacancies, the recombination of electrons and holes is inhibited, further promoting the generation of ROS.

[0022] The unsaturated tungsten oxide-coated bismuth ferrite nanomaterial of the present invention has a significant inhibitory effect on tumors under ultrasound and 1064nm laser irradiation, and has good biocompatibility, and no obvious pathological changes are found in H&E tissue staining of major organs. Description of the drawings:

[0023] Figure 1 It is BFO and WO 3-X -XRD pattern of BFO;

[0024] Figure 2 It is BFO and WO 3-X - Particle size and Zeta potential of BFO;

[0025] Figure 3 It is WO 3-X -Comparison of hydroxyl radicals produced by BFO under piezoelectric-optical stimulation;

[0026] Figure 4 It is BFO and WO 3-X -BFO temperature rise comparison chart under lighting conditions;

[0027] Figure 5 Different concentrations of WO 3-X - Cytotoxicity of BFO incubated with 4T1 cells for 24 hours;

[0028] Figure 6 Different concentrations of WO 3-X - Cytotoxicity of BFO after uptake by 4T1 cells and 5 min of ultrasound;

[0029] Figure 7 This is the curve of tumor volume changes in each group of 4T1 tumor-bearing mice during the treatment cycle;

[0030] Figure 8 This is a comparison chart of tumor weights in each group of 4T1 tumor-bearing mice after treatment;

[0031] Fig. 9 This is the body weight change curve of each group of 4T1 tumor-bearing mice during the treatment cycle. Specific implementation method:

[0032] Implementation 1:

[0033] Step 1: Weigh the raw materials bismuth nitrate (pentahydrate, 0.99 mmol) and ferric nitrate (nonahydrate, 1 mmol) respectively, dissolve the bismuth nitrate in dilute nitric acid, ultrasonically dissolve for a period of time, and then add ferric nitrate until it is completely dissolved;

[0034] Step 2: adjusting the pH of the solution to 10, then centrifuging, drying the obtained precipitate in a vacuum drying oven at 60 degrees for 12 hours, grinding the obtained solid powder and calcining it in a tube furnace at 500 degrees in air for 2 hours, and further washing it by alternating centrifugation with dilute nitric acid and deionized water for 3 times to obtain pure phase bismuth ferrite;

[0035] Step 3: Weigh 0.17 g of raw material ethanol tungsten, add 50 ml of anhydrous ethanol (VI, 37 mmol), stir in a 70°C oil bath until completely dissolved, add 400 mg of pure phase bismuth ferrite, and sonicate for 20-30 minutes;

[0036] Step 4: Transfer the mixed solution to a reactor, react in an oven at 200 degrees for 22 hours, wash the reaction product with acid, water, and alcohol alternately twice, and then dry it in a vacuum drying oven for 12 hours to obtain unsaturated tungsten oxide-coated bismuth ferrite nanoparticles;

[0037] Step 5: 4T1 mouse breast cancer cells were digested with trypsin and resuspended in 1064 culture medium in a 96-well plate for MTT toxicity test and treatment effect test;

[0038] Step 6: 4T1 mouse breast cancer cells were digested with trypsin and centrifuged, then resuspended in PBS solution to 1×10 6 100ul of single cell suspension was subcutaneously injected into female Balb / c mice weighing about 18g to establish a mouse breast cancer model.

[0039] Step 7: Divide the mice into five groups: PBS, PBS+US, WO 3-X -BFO、WO 3-X -BFO+US、WO 3-X -BFO+US+1064 group, tumor volume in each group reached 50mm 3 Treatment started at around 14:00 p.m., and each group was injected intratumorally with PBS and WO 3-X - BFO solution 100ul, ultrasound treatment for 5min;

[0040] Step 8. The weight and tumor volume of mice were recorded every other day. After the 12-day treatment cycle, the mice were killed, the tumor tissues were removed, and the main organ sections were selected for H&E staining.

[0041] The following experiments were used to verify the effect of the invention:

[0042] 1. BFO and WO3-X -Preparation and characterization of BFO

[0043] According to the XRD results ( Figure 1 ) observed that the main phase of the BFO sample is a rhombohedron (perovskite structure) with an R3c space group, which is basically consistent with the standard card JCPDS No.97-023-7538 of bismuth ferrite. The diffraction peaks 2θ=31.8° and 32.0° correspond to the (121) and (011) crystal planes, respectively, which indicates that pure bismuth ferrite nanomaterials have been successfully synthesized. Accompanied by the coating of unsaturated tungsten oxide, the newly appeared diffraction peaks 2θ=23.8° and 49.2° correspond to WO 3-X The (110) and (102) crystal planes in the standard card JCPDS No.00-053-0434. The above results also indicate the successful preparation of unsaturated tungsten oxide-coated bismuth ferrite nanomaterials.

[0044] 2.BFO and WO 3-X -Hydration radius and zeta potential of BFO

[0045] According to the test results of hydrodynamic radius, such as Figure 2 As shown in the figure, the hydrated particle size of BFO is 378.6nm, and the WO prepared by hydrothermal method 3-X -BFO's hydrated particle size dropped to 202.1nm. At the same time, according to the test results of Zeta potential, the coating of unsaturated tungsten oxide made its surface potential more negative, from -0.15mV to -3.96mV. It can be seen that the bismuth ferrite synthesized by the coprecipitation method has a serious agglomeration phenomenon because its surface potential is close to 0. After the unsaturated tungsten oxide is coated on the surface of bismuth ferrite by the hydrothermal method, the surface potential becomes negative, the dispersibility of the composite material in water is effectively improved, and the agglomeration problem is alleviated, thereby significantly reducing its hydrated particle size.

[0046] 3. WO 3-X - Comparison of ROS generation in BFO piezoelectric photoresponse and its photothermal effect

[0047] Terephthalic acid (TA) was used as a probe to detect the generation of hydroxyl radicals (·OH), such as Figure 3 As shown, WO 3-X -BFO, under the action of ultrasound, produces ·OH which reacts with TA to generate a substance with a characteristic fluorescence emission peak at 412nm. As the ultrasound time increases, the fluorescence intensity increases continuously, indicating that more ·OH is produced. 3-X Under the synergistic effect of ultrasound and 1064nm laser irradiation, the fluorescence intensity of -BFO was enhanced to different degrees under the same action time compared with ultrasound alone. The largest increase was observed after 5min, which was 1.71 times that of the ultrasound alone group (the value at the 412nm peak value), indicating that WO 3-X-BFO produced more ROS under the synergistic effect of ultrasound and light. When hydrogen peroxide was added, the fluorescence intensity increased at different intensities compared with the group without hydrogen peroxide at the same exposure time. After 5 minutes of exposure, the fluorescence intensity of the group with hydrogen peroxide was 1.17 times that of the group without hydrogen peroxide. This shows that WO 3-X -BFO can convert endogenous hydrogen peroxide into ·OH for chemodynamic therapy (CDT).

[0048] Use infrared radiometer to verify the photothermal properties of materials ( Figure 4 ), under the action of 1064nm laser, WO 3-X The temperature of the -BFO group rose rapidly within 3 minutes and reached 49.7°C within 10 minutes of illumination. 3-X -BFO nanomaterials have excellent photothermal conversion efficiency under near-infrared light.

[0049] 4. WO 3-X -Biocompatibility of BFO on 4T1 cells and sonodynamic therapy (SDT) effect

[0050] Different concentrations of WO 3-X -BFO was co-incubated with mouse breast cancer 4T1 cells for 24 h, and the cell survival rate was detected by MTT colorimetry ( Figure 5 ). When the material concentration was 200 μg / ml, the cell survival rate was higher than 95%, indicating that WO 3-X -BFO nanomaterials have low toxicity and good biocompatibility. 3-X -After the BFO nanomaterials were taken up by 4T1 cells, the cell survival rate was detected by MTT colorimetry after 5 minutes of ultrasound exposure to observe the sonodynamic therapeutic effect of the material at the cellular level ( Figure 6 ).WO 3-X -BFO material has obvious cytotoxicity to cells under ultrasound at a concentration of 100μg / ml, and the cell survival rate is only 7.95%, which is lower than that of WO without ultrasound. 3-X -The survival rate of the BFO group decreased by 92.05%. 3-X -BFO can act as a sonosensitizer and produce high toxicity to cells under ultrasound.

[0051] 5. WO 3-X -Verification of the tumor inhibition effect of BFO in vivo

[0052] In vivo evaluation of WO 3-X -The therapeutic effect of BFO on 4T1 tumor-bearing mice, WO 3-X - The tumors of mice in the BFO+US+1064 experimental group were significantly inhibited, with an average tumor inhibition rate of 78.14% ( Figure 7 ).WO3-X -BFO+US、WO 3-X -BFO+US+1064 experimental groups showed significant differences compared with the control group (P<0.01). Compared with ultrasound alone, the experimental group with 1064nm laser also showed significant differences (P<0.01) ( Figure 8 During the entire treatment period, there was no significant change in the body weight of mice in each group ( Fig. 9 ), H&E tissue staining of major organs showed no obvious pathological changes, indicating the safety of the material in vivo.

[0053] The combined therapy of sonodynamic and photodynamic therapy is a promising tumor treatment method. 3-X -BFO composite material, on the one hand, triggers the piezoelectric effect of the material under the action of external ultrasonic pressure. In addition, compared with other piezoelectric materials, the presence of oxygen vacancies can inhibit the premature recombination of electrons and holes. The generated electrons and holes generate active oxygen such as hydroxyl radicals. At the same time, under the action of external 1064nm laser, WO 3-X -BFO produces photogenerated electrons, which in turn can also generate ROS, and has good photothermal efficiency, which can inactivate tumor cells by increasing the temperature. 3-X -BFO has a higher ROS production rate, combining oxidative damage with thermal damage, thus achieving a better tumor inhibitory effect.

Claims

1. Application of an unsaturated tungsten oxide-coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment, characterized in that The preparation and detection method is carried out according to the following steps: Step 1: Weigh the raw materials bismuth nitrate (pentahydrate, 0.99 mmol) and ferric nitrate (nonahydrate, 1 mmol) respectively, dissolve the bismuth nitrate in dilute nitric acid, ultrasonically dissolve for a period of time, and then add ferric nitrate until it is completely dissolved; Step 2: adjusting the pH of the solution to about 10, centrifuging the solution to obtain a precipitate, drying it in a vacuum drying oven at 60 degrees for 12 hours, grinding the obtained solid powder and calcining it in a tube furnace at 500 degrees in air for 2 hours, and further washing it by alternating centrifugation with dilute nitric acid and deionized water for 3 times to obtain pure phase bismuth ferrite; Step 3: Weigh 0.17 g of tungsten (VI) ethoxide, add 50 ml of anhydrous ethanol, stir in a 70°C oil bath until completely dissolved, then add 400 mg of pure bismuth ferrite, and disperse evenly by ultrasonication; Step 4: Transfer the mixed solution obtained in step 3 to a reactor, and react in an oven at 200 degrees for 22 hours. After the reaction is completed, the reaction product is centrifuged and washed several times, and then placed in a vacuum drying oven for drying to obtain unsaturated tungsten oxide-coated bismuth ferrite nanoparticles; Step 5: 4T1 mouse breast cancer cells were digested with trypsin and resuspended in 1064 culture medium in a 96-well plate for MTT toxicity test and treatment effect test; Step 6: 4T1 mouse breast cancer cells were digested with trypsin and centrifuged, then resuspended in PBS solution to form a single cell suspension, and injected subcutaneously into female Balb / c mice weighing about 18 g to construct a mouse breast cancer model; Step 7: Divide the mice into five groups: PBS, PBS+US, WO 3-X -BFO、WO 3-X -BFO+US、WO 3-X -BFO+US+1064 group, tumor volume in each group reached 50mm 3 Treatment started at around 14:00 p.m., and each group was injected intratumorally with PBS or WO 3-X -BFO solution 100ul, treatment for 5min; Step 8. The weight and tumor volume of mice were recorded every other day. After the 12-day treatment cycle, the mice were killed, the tumor tissues were removed, and the main organ sections were selected for H&E staining.

2. The use of an unsaturated tungsten oxide-coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment according to claim 1, characterized in that In step 1, bismuth nitrate and ferric nitrate need to be added in sequence until they are completely dissolved. The ratio of the dilute nitric acid solution should be water: concentrated nitric acid = 32:

11.

3. The use of an unsaturated tungsten oxide-coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment according to claim 1, characterized in that The concentration of ethanol tungsten (VI) after complete dissolution in step 3 is 37 mM.

4. The use of an unsaturated tungsten oxide-coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment according to claim 1, characterized in that The concentration of 4T1 cell suspension in step 6 is 1×10 6 Pieces / ml.

5. The use of an unsaturated tungsten oxide-coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment according to claim 1, characterized in that In step 7, the drug concentration of injection is 20 mg / kg, the ultrasound frequency is 1 MHz, and the power is 3 W / cm 2 , the optical power of the 1064nm laser is 1W / cm 2 .

6. The use of an unsaturated tungsten oxide-coated bismuth ferrite piezoelectric semiconductor composite material in tumor treatment according to claim 1, characterized in that Step 8: Validation of WO at the animal level 3-X -BFO has excellent performance as a piezoelectric sonosensitizer and photothermal agent. The average tumor inhibition rate in 4T1 tumor-bearing mice was 78.14%, and tumor ablation was achieved through oxidative damage and thermal damage under the action of ultrasound and 1064nm laser.